QP-Prostate®

Your solution for prostate MRI based on Artificial Intelligence, providing automated prostate segmentation and lesion detection*. CE, UKCA mark and FDA 510(k) cleared.

Competitive Advantages

Prost1

The best-in-class in clinical evidence

Quibim is not only setting new benchmarks in diagnostic accuracy but also elevating clinical expectations. With a 10% increase in sensitivity, we enable healthcare providers to make faster and more precise decisions, improving patient outcomes.

Porst2

Systematic & targeted biopsies as ground truth

With our pioneering dual-validation approach, Quibim’s algorithms are not just robust but virtually unbeatable. Our commitment sets a new gold standard in diagnostic precision.

Pros3

Fully automated workflow

We provide clinicians with solutions that enhance efficiency and simplify their daily tasks, allowing them to focus more on patient care than on process.

Sin-título-1

Regulatory QP-Prostate status

Quibim is not just compliant with international regulatory standards but leads the way in achieving approvals across major markets, including a 510k clearance that sets us apart in the US market*.

QP-Prostate Competitive Advantages

Prost1
Porst2
Pros3
Sin-título-1
  • Prost1

    1. Best-in-class in clinical evidence

    Quibim sets a new standard in diagnostic precision, offering a 10% increase in sensitivity, which translates into more accurate and timely clinical decisions.
  • Porst2

    2. Systematic & targeted biopsies as ground truth

    With Quibim’s dual-validation approach using both systematic and targeted biopsies, our algorithms are robust and calibrated against the most comprehensive ground truth data in the industry.
  • Pros3

    3. Fully automated workflow

    Our workflow integrates seamlessly into existing systems, offering clinicians a streamlined, efficient diagnostic process that is unmatched in the industry.
  • Sin-título-1

    4. Regulatory status

    Quibim is not just compliant with international regulatory standards but leads the way in achieving approvals across major markets, including a 510k clearance that sets us apart in the US market*.

Competitive Advantages

QP-Prostate® is the most complete and powerful AI solution to improve prostate cancer detection.
resume

QP-Prostate: top choice over competitors

Prost8

 

 

Best-in-class in clinical evidence

Quibim is not only setting new benchmarks in diagnostic accuracy but also elevating clinical expectations. With a 10% increase in sensitivity, we enable healthcare providers to make faster and more precise decisions, improving patient outcomes.

 

 

 

Prost7

 

Systematic & targeted biopsies as ground truth

With Quibim’s dual-validation approach using both systematic and targeted biopsies, our algorithms are robust and calibrated against the most comprehensive ground truth data in the industry.

 

 

Prost6

 

Fully automated workflow

We provide clinicians with solutions that enhance efficiency and simplify their daily tasks, allowing them to focus more on patient care than on process.

 

 

Prost5

Regulatory QP-Prostate status

Quibim is not just compliant with international regulatory standards but leads the way in achieving approvals across major markets, including a 510k clearance that sets us apart in the US market*.